1. Chemotherapy infusion – ambulatory and complex regimens
  2. Bone marrow Transplant – Autologous and Allogeneic grafts
  3. CAR T cell therapy for leukemia, lymphoma and multiple myeloma
  4. Radiation Therapy, including VMAT, 3D conformal IGRT, SBRT, Brachytherapy and Proton Beam Radiation
  5. Hereditary Genetic Assessment, Testing and Counselling
  6. Next-generation sequencing (NGS) Molecular Tumour Testing
  7. Molecular Residual Disease (MRD) testing and Liquid Biopsies
  8. Ex-vivo chemosensitivity testing of Tumour cells
  9. Intraoperative chemotherapy including HIPEC and Isolated Limb Perfusion
  10. Molecular Risk Stratification Tests, e.g. Oncotype DX and MammaPrint
  11. Clinical Trials with novel targeted agents, immunotherapy and antibody-drug conjugates

Panel Partners

Extended Panel

WhatsApp